EP1330444B1
(en)
|
2000-11-01 |
2011-03-23 |
Millennium Pharmaceuticals, Inc. |
Nitrogenous heterocyclic compounds and process for making them
|
AU2003301282B2
(en)
|
2002-10-15 |
2009-04-30 |
Otsuka Pharmaceutical Co., Ltd. |
1-substituted 4-nitroimidazole compound and process for producing the same
|
JP4761756B2
(ja)
*
|
2003-10-31 |
2011-08-31 |
大塚製薬株式会社 |
2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物
|
DK1678185T3
(da)
|
2003-10-31 |
2008-12-08 |
Otsuka Pharma Co Ltd |
2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose
|
TWI300409B
(en)
|
2004-02-18 |
2008-09-01 |
Otsuka Pharma Co Ltd |
Method for producing 4-nitroimidazole compound
|
US7485727B2
(en)
|
2004-03-31 |
2009-02-03 |
Nippon Soda Co., Ltd. |
Cyclic amine compound and pest control agent
|
JP4787529B2
(ja)
*
|
2004-04-09 |
2011-10-05 |
大塚製薬株式会社 |
医薬組成物
|
JP4789966B2
(ja)
*
|
2004-04-09 |
2011-10-12 |
大塚製薬株式会社 |
医薬組成物
|
ES2337728T3
(es)
*
|
2005-06-20 |
2010-04-28 |
Schering Corporation |
Piperidinas sustituidas unidas a carbono y sus derivados utiles como antagonistas de histamina h3.
|
DK1906926T3
(da)
*
|
2005-07-28 |
2011-01-31 |
Otsuka Pharma Co Ltd |
Farmaceutisk sammensætning omfattende 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolderivater
|
JP5105818B2
(ja)
*
|
2005-10-05 |
2012-12-26 |
大塚製薬株式会社 |
医薬組成物
|
TW201434467A
(zh)
*
|
2005-10-05 |
2014-09-16 |
Otsuka Pharma Co Ltd |
抗結核治療藥物及含彼之套組
|
BRPI0616667B1
(pt)
*
|
2005-10-06 |
2017-07-18 |
Nippon Soda Co. , Ltd. |
Compounds of cyclical amine or salts thereof or non-oxides thereof, and agents for control of fever
|
TW200800268A
(en)
*
|
2005-11-04 |
2008-01-01 |
Otsuka Pharma Co Ltd |
Medicinal composition showing improved drug absorbability
|
EP1968961A2
(en)
|
2005-12-21 |
2008-09-17 |
Decode Genetics EHF |
Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
|
EP1986637A1
(en)
*
|
2006-02-13 |
2008-11-05 |
Laboratoires Serono SA |
Sulfonamide derivatives for the treatment of bacterial infections
|
JP2007297305A
(ja)
*
|
2006-04-28 |
2007-11-15 |
Daiso Co Ltd |
N−(2,3−エポキシ−2−メチルプロピル)フタルイミドの製造法
|
WO2008106128A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
AR070301A1
(es)
|
2007-05-08 |
2010-03-31 |
Otsuka Pharma Co Ltd |
Compuesto epoxi y metodo para producir el mismo
|
ES2395081T3
(es)
*
|
2007-07-26 |
2013-02-08 |
Vitae Pharmaceuticals, Inc. |
Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
|
US7884114B2
(en)
*
|
2007-08-15 |
2011-02-08 |
Glaxo Group Limited |
Compounds
|
US20100222349A1
(en)
*
|
2007-10-16 |
2010-09-02 |
Glaxo Group Limited |
Quinoline derivatives used to treat inflammatory and allergic diseases
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
WO2009075835A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
CA2712500A1
(en)
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2009102428A2
(en)
*
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
WO2009102460A2
(en)
*
|
2008-02-15 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
CA2718264A1
(en)
*
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
CA2712613C
(en)
*
|
2008-03-26 |
2017-02-28 |
Global Alliance For Tb Drug Development |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
JP5538365B2
(ja)
|
2008-05-01 |
2014-07-02 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
|
US8569292B2
(en)
|
2008-05-01 |
2013-10-29 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
JP5451752B2
(ja)
*
|
2008-05-01 |
2014-03-26 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
EP2300461B1
(en)
*
|
2008-05-01 |
2013-04-17 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
RU2539979C2
(ru)
|
2008-07-25 |
2015-01-27 |
Вайтаи Фармасьютиклз, Инк. |
Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
|
JP5777030B2
(ja)
|
2008-07-25 |
2015-09-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
EP2326631A4
(en)
*
|
2008-08-18 |
2012-03-21 |
Univ Yale |
MODULATORS OF MIF
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
WO2010143007A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik |
Method for the production of 2-halogeno-4-nitroimidazole
|
US8558005B2
(en)
*
|
2008-08-21 |
2013-10-15 |
Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik |
Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
|
WO2010089303A1
(en)
|
2009-02-04 |
2010-08-12 |
Boehringer Ingelheim International Gmbh |
CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
KR20120061771A
(ko)
*
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|
UA109255C2
(ru)
|
2009-04-30 |
2015-08-10 |
Берінгер Інгельхайм Інтернешнл Гмбх |
Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
|
EP2440537A1
(en)
|
2009-06-11 |
2012-04-18 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
WO2011002910A1
(en)
|
2009-07-01 |
2011-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US9198913B2
(en)
|
2009-07-31 |
2015-12-01 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
KR101738868B1
(ko)
|
2009-07-31 |
2017-05-23 |
글로벌 알리앙스 포 티비 드럭 디벨롭먼트 |
니트로이미다조옥사진 및 니트로이미다조옥사졸 동족체 및 이들의 용도
|
CA2769359C
(en)
*
|
2009-07-31 |
2017-03-07 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
US20120219500A1
(en)
|
2009-10-26 |
2012-08-30 |
Fujifilm Ri Pharma Co., Ltd. |
Diagnostic agent for infectious diseases
|
TW201200523A
(en)
|
2010-01-29 |
2012-01-01 |
Otsuka Pharma Co Ltd |
Synthetic intermediate of oxazole compound and method for producing the same
|
GB201012209D0
(en)
*
|
2010-05-31 |
2010-09-08 |
Ge Healthcare Ltd |
In vivo imaging agent
|
WO2011159760A1
(en)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
JP5813106B2
(ja)
|
2010-06-25 |
2015-11-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
|
EP2635268A1
(en)
|
2010-11-02 |
2013-09-11 |
Boehringer Ingelheim International GmbH |
Pharmaceutical combinations for the treatment of metabolic disorders
|
EP2697232B1
(en)
|
2011-04-15 |
2016-05-18 |
Otsuka Pharmaceutical Co., Ltd. |
6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides
|
JP2015006994A
(ja)
*
|
2011-10-28 |
2015-01-15 |
大正製薬株式会社 |
ジヒドロイミダゾオキサゾール誘導体
|
US9572809B2
(en)
|
2012-07-18 |
2017-02-21 |
Spero Trinem, Inc. |
Combination therapy to treat Mycobacterium diseases
|
FR3000064A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
|
US9845330B2
(en)
*
|
2013-10-04 |
2017-12-19 |
Council Of Scientific & Industrial Research |
6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof
|
CN103524492A
(zh)
*
|
2013-10-23 |
2014-01-22 |
中国药科大学 |
侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
|
AR101704A1
(es)
|
2014-08-28 |
2017-01-04 |
Otsuka Pharma Co Ltd |
Compuestos heterocíclicos fusionados
|
US9822126B1
(en)
|
2014-10-21 |
2017-11-21 |
Council Of Scientific & Industrial Research |
Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
|
CN105732659B
(zh)
*
|
2014-12-12 |
2019-07-16 |
上海阳帆医药科技有限公司 |
硝基咪唑类化合物及其制备方法和在制药中的用途
|
MX2017009810A
(es)
*
|
2015-01-29 |
2018-11-09 |
Medshine Discovery Inc |
Derivado de nitroimidazol contra tuberculosis pulmonar.
|
EA201792154A1
(ru)
*
|
2015-03-27 |
2018-02-28 |
Оцука Фармасьютикал Ко., Лтд. |
Способ получения 1-(4-гидроксифенил)-4-(4- трифторметоксифенокси)пиперидина или его соли
|
CN106317072B
(zh)
*
|
2015-06-17 |
2020-03-17 |
盟科医药技术(上海)有限公司 |
用于分枝杆菌感染治疗的杂环化合物及其应用
|
WO2017146246A1
(ja)
|
2016-02-26 |
2017-08-31 |
大塚製薬株式会社 |
ピペリジン誘導体
|
CN105859628B
(zh)
*
|
2016-04-19 |
2018-08-07 |
清远职业技术学院 |
一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
|
RU2019104974A
(ru)
*
|
2016-07-22 |
2020-08-24 |
Медшайн Дискавери Инк. |
Кристалл и соль нитроимидазола и способ их изготовления
|
PL3668879T3
(pl)
*
|
2017-08-16 |
2022-02-21 |
Glaxosmithkline Intellectual Property Development Limited |
Nowe związki
|
WO2019240104A1
(ja)
|
2018-06-11 |
2019-12-19 |
大塚製薬株式会社 |
デラマニド含有組成物
|
CN109705022A
(zh)
*
|
2018-12-28 |
2019-05-03 |
上海彩迩文生化科技有限公司 |
一种芳香胺中间体的制备方法
|
CN112300192B
(zh)
*
|
2019-08-02 |
2023-08-11 |
南京长澳医药科技有限公司 |
硝基咪唑类化合物及其制备方法和用途
|
CN110483549B
(zh)
*
|
2019-08-30 |
2021-03-05 |
沈阳药科大学 |
一种硝基咪唑吡喃类抗结核药物的制备方法
|
CN110615800A
(zh)
*
|
2019-10-16 |
2019-12-27 |
李丽丽 |
硝基咪唑类化合物及其制备方法和用途
|
CN112156088B
(zh)
*
|
2020-10-30 |
2021-08-31 |
健民药业集团股份有限公司 |
一种化合物在制备结核分枝杆菌抑制剂中的用途
|
CN113603706A
(zh)
*
|
2021-08-04 |
2021-11-05 |
深圳市泰力生物医药有限公司 |
德拉马尼的晶型、含有该晶型的活性药物和药物组合物
|
CN115368252B
(zh)
*
|
2022-09-19 |
2024-01-12 |
西北农林科技大学 |
一种4-胺基酚类衍生物及应用
|
CN116640106B
(zh)
*
|
2023-05-11 |
2024-03-08 |
郑州大学 |
一种苯基哌嗪类化合物及其制备方法、应用
|